Previous 10 | Next 10 |
During the last Fed rate raising cycle, it took the Federal Reserve five years to raise the fed funds rate to 2.50%. The Fed kept rates far too low for far too long and now we are dealing with the consequences. Both fiscal and monetary policy have been highly inflationary, and we are ...
MedTech stocks are trading sharply higher on Tuesday after the industry bellwether Johnson & Johnson (JNJ) reported better than expected 1Q 2022 sales for its MedTech segment. The iShares U.S. Medical Devices ETF (NYSEARCA:IHI) has recorded the best intraday gain since June 2020, dri...
Driven by the makers of life sciences tools, the healthcare stocks in the S&P 500 have pared the gains made last week as the sector is set to become the second worst performer in the broader index on Tuesday. IDEXX Laboratories (IDXX), Agilent Technologies (A), Bio-Rad Laboratories (BIO) ...
Typically, we look at net new highs as a way to confirm moves in the broader market. At the high last Wednesday, over 90% of S&P 500’s new highs came from defensive sectors. In other words, defensives have been a notable pocket of strength recently. For further de...
Stock markets fell in the first quarter as Russia’s invasion of Ukraine destabilized the growth outlook, amplified concerns about rising interest rates and unleashed geopolitical risks. While the conflict has created many uncertainties, we believe the impact of persistent infla...
Goldman Sachs has weighed in on the impact of macro factors on the MedTech stocks as the COVID recovery develops into a potential tailwind for a sector hurt by the pandemic’s impact on medical procedures. As part of the analysis, the firm has downgraded Baxter International (NYSE:BAX -...
Investing in individual stocks can make some investors nervous due to the amount of necessary research and the risk associated with volatility in the market. One way to quiet those nerves is to place your money into exchange-traded funds that follow a market or sector index and are managed ...
iShares U.S. Medical Devices ETF (IHI) - $0.0050. 30-Day SEC Yield of 0.34% as of Feb. 28. Payable Mar 30; for shareholders of record Mar 25; ex-div Mar 24. For further details see: iShares U.S. Medical Devices ETF declares quarterly distribution of $0.0050
Hurt by the underperformance of several medical device makers on Wednesday, the S&P 500 Healthcare Index has lagged all but one sector in the benchmark index. Notable decliners include, ResMed (RMD -6.8%), Edwards Lifesciences (EW -4.2%), Boston Scientific (BSX -3.7%), and Stryker Corpora...
The XBI biotech index peaked early last year, and it's now back to where it was in April of 2020. The biopharma stocks got powerfully inflated during 2020 by the pandemic. The biotech stocks are going to need some good news to get moving again. For further details see: B...
News, Short Squeeze, Breakout and More Instantly...
iShares U.S. Medical Devices Company Name:
IHI Stock Symbol:
NYSE Market:
2024-07-12 08:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-22 11:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-21 21:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...